Diplomat receives limited distribution contract for Imbruvica (ibrutinib)
Flint, Mich. –Nov. 14, 2013 — Diplomat, the country’s largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA™ (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration (FDA) for the treatment of Mantle Cell Lymphoma (MCL).
IMBRUVICA™, a Brutton’s Tyrosine Kinase (BTK) Inhibitor, is an oral drug available in 140 mg, 90 capsule bottles and 140 mg, 120 capsule bottles. Full prescribing information is available at www.IMBRUVICA.com.
“We are pleased to partner with Pharmacyclics and Janssen Biotech, Inc. as a specialty pharmacy provider of IMBRUVICA™,” said Gary Kadlec, R.Ph., President of Diplomat. “Diplomat has proven expertise in handling limited distribution drugs and an industry-wide reputation for comprehensive patient care outreach that improves patient compliance, adherence and outcomes.”
Diplomat’s high-tech, high-touch approach, which achieved 98% patient and prescriber satisfaction ratings in 2012, includes timely prescription delivery, side effect management support and 24 hour access to pharmacists and other specialists on the continuum of care. For IMBRUVICA™, Diplomat will also provide prior authorization management, co-pay support, and assistance to patients that meet certain financial criteria.
IMBRUVICA™ is commercially available immediately.
Contact: Barbara Fornasiero, EAFocus Communications: 586.817.8414, email@example.com; Jim Kosmerick, Diplomat: 810.768.9530, JKosmerick@diplomatpharmacy.com; Gary Rice, R.Ph., Diplomat: 810.768.9863, GRice@diplomatpharmacy.com
@DiplomatRx@BuntyLUFC We appreciate you reaching out. Would you mind direct messaging us so we can help?2 days ago
@DiplomatRxOur Navigating Patient Engagement webinar is available on demand. Sign up at https://t.co/LN1qWkrCZp to watch the r… https://t.co/RaQGhk3xF72 days ago
@SpecialtyPharmRT @SpecialtyPharm: Specialty Pharmacies Earn High Marks in First NASP Patient Satisfaction @Rx_Specialty Survey #NASP2017 https://t.co/B0k…2 days ago
@DiplomatRxDid you miss yesterday's Navigating Patient Engagement webinar? If so, register below to view it on demand.… https://t.co/SHcloxFFXP2 weeks ago
@DiplomatRx"We're going live today with our new pharma webinar! Tune in at 12 p.m. ET at the link below."—Cheryl Allen… https://t.co/6ejXSvYDKA2 weeks ago